Anderson-Fabry disease is a rare disease associated with progressive accumulation of globotriaosylceramide in visceral organs and vascular endothelium. The disease primarily affects male patients. It has long been considered that females are asymptomatic carriers of Anderson-Fabry disease. However, recent results demonstrated a significant proportion of symptomatic affected females. We present our experience in the treatment of patients with Anderson-Fabry disease having received allograft from deceased donor, as well as follow-up of patients having received allograft from donor with unrecognized Anderson-Fabry disease.